Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 9, 1998, Pages 839-849

  Umehara, Fujio ^a   Okada, Yasunori ^b   Fujimoto, Noboru ^c   Abe, Mayumi ^a   Izumo, Shuji ^d   Osame, Mitsuhiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^d NONE

Author keywords

Blood brain barrier; Decorin; HAM TSP; HTLV I; Matrix metalloproteinases; Tissue inhibitors of metalloproteinases

Indexed keywords

DECORIN; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CYTOTOXIC T LYMPHOCYTE; EXTRACELLULAR MATRIX; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPINAL CORD DISEASE;

EID: 0031685213     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199809000-00005     Document Type: Article

References (46)

1. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human lymphotropic virus type-I and adult T cell leukemia-like cells. Ann Neurol 1987;21:117-22
2. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-10
3. Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990;96:103-23
4. Moore GRW, Traugott U, Scheinberg LC, Raine CS. Tropical spastic paraparesis: A model of virus-induced, cytotoxic T-cell mediated demyelination? Ann Neurol 1989;26:523-30
5. Umehara F, Izumo S, Nakagawa M, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1993;52:424-30
6. Umehara F, Izumo S, Ronquillo AT, et al. Cytokinc expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1994;53:72-77
7. Umehara F, Nakamura A, Izumo S, et al, Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: A possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol 1994;53:617-24
8. Umehara F, Izumo S, Takeya M, et al. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol 1996;91:343-50
9. Rosenberg GA, Kornfeld M, Estrada E, Kelly RO, Liotta LA, Steler-Stevenson WG. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 1992;576:203-7
10. Zhang J, Fujimoto N, Iwata K, Sakai T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies. Clin Chim Acta 1993;221:91-103
11. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayasaka T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 1993;221:91-103
12. Obata K, Iwata K, Okada Y, et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta 1992;211:59-72
13. Ohuchi E, Azumano I, Yoshida S, Iwata K, Okada Y. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 7 (matrilysin) using monoclonal antibodies. Clinica Chimica Acta 1996;244:181-98
14. Matsuki H, Fujimoto N, Iwata K, Knauper V, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 8 (neutrophil collagenase) using monoclonal antibodies. Clinica Chimica Acta 1996;244:129-43
15. Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayasaka T. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 1994;231:79-88
16. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods 1990;127:103-8
17. Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayasaka T. A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinase-2 (TIMP-2) using monoclonal antibodies. Clin Chim Acta 1993;220:31-45
18. Tsuchiya Y, Endo Y, Sato H, et al. Expression of type IV collagenases in human tumor cell lines that can from liver colonies in chick embryos. Int J Cancer 1993;56:46-51
19. Okada Y, Naka K, Kawamura K, et al. Localization of matrix metalloproteinases 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: Implications for bone resorption. Lab Invest 1995;72:311-12
20. Davies B, Miles DW, Happerfield LC, et al. Activity of type IV collagenases in benign and malignant breast disease. Brit J Cancer 1993;67:1126-31
21. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 1996;69:9-16
22. Collier IE, Wilheim SM, Eisen AZ, et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degradading basement membrane collagen. J Biol Chem 1988;263:6579-87
23. Okada Y, Morodomi T, Enghild JJ, et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts: Purification and activation of the precursor and enzyme properties. Eur J Biochem 1990;194:721-30
24. Okada Y, Gonoji Y, Naka K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymatic properties. J Biol Chem 1992;267:21712-9
25. Yamada T, Miyazaki K, Koshikawa N, Takahashi M, Akatsu H, Yamamoto T. Selective localization of gelatinase A, an enzyme degrading β-amyloid protein, in white matter microglia and in Schwann cells. Acta Neuropathol 1995;89:199-203
26. Gijbels K, Masure S, Carton H, Opdenakker G. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 1992;41:29-34
27. Rosenberg GA, Dencoff JE, Correa N Jr, Reiners M, Ford CC. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: Relation to blood-brain barrier injury. Neurology 1996;46:1626-32
28. Giraudon P, Buart S, Bernard A, Thomasset N, Belin MF. Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus Human T-lymphotropic virus type I (HTLV-I). Prog Neurobiol 1996;49:169-84
29. Maeda A, Sobel RA. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 1996;55:300-309
30. Cuzner ML, Gveric D, Strand C, et al. The expression of tissue-type plasminogen activator, matrix metalloproteinases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison stages in lesion evolution. J Neuropathol Exp Neurol 1996;55:1194-204
31. Romanic AM, Madri JA. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol 1994;125:1165-78
32. Brenner D, O'Hara M, Angel P, Choffier M, Karim M. Prolonged activation of jun and collagenases gene by tumor necrosis factor-alpha. Nature 1989;337:661-63
33. Sato H, Seiki M. Regulatory mechanism of 92kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1992;8:395-405
34. Moritoyo T, Reinhart TA, Moritoyo H, et al. Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 1996;40:84-90
35. Peres N, Perillo E, Zucker S. Localization of tissue inhibitor of matrix metalloproteinases in Alzheimer's disease and normal brain. J Neuropathol Exp Neurol 1995;54:16-22
36. Pogany G, Vogel KG. The interaction of decorin core protein fragments with type I collagen. Biochem Biophyis Res Commun 1992;189:165-72
37. Krusins T, Rouslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Biochemistry 1986;83:7683-87
38. Yamaguchi Y, Mann D, and Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990;346:281-84
39. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y. Degradation of decorin by matrix metalloproteinases; identification of the cleavage sites, kinetic analyses and transforming growth factor-β 1 release. Biochem J 1997;322:809-14
40. Gijbels K, Gallardy RE, Steiman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibition of matrix metalloproteinases. J Clin Invest 1994;94:2177-82
41. Clements JM, Cossins JA, Wells GMA, et al. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumor necrosis factor-α inhibitor. J Neuroimmunol 1997;74:85-94
42. Goodkin DE. Interferon beta-1b. Lancet 1994;344:1057-60
43. Leppert D, Waubant E, Burk MR, Oksenberg JR, Hauser SL. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis. Ann Neurol 1996;40:846-52
44. Stüve O, Dooley NP, Uhm JH, et al. Interferonβ-1b decreases the migration of T lymphocytes in vitro. Effect on matrix metalloproteinase-9. Ann Neurol 1996;40:853-63
45. Gearing AJH, Beckett P, Christodoulou M, et al. Processing tumor necrosis factor-α precursor by metalloproteinases. Nature 1994;370: 555-57
46. McGeehan GM, Becherer JD, Bast Jr RC, et al. Regulation of tumor necrosis factor-a processing by a metalloproteinase inhibitor. Nature 1994;370:558-61